ROSE_2A | R Documentation |
Kaplan-Meier digitized data from ROSE, figure 2A (PMID 25185099). A reported sample size of 1,144 for a primary endpoint of PFS in breast cancer.
ROSE_2A
A data frame of 1,144 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (pbo_doc, ram_doc) | |
Mackey JR, Ramos-Vazquez M, Lipatov O, et al. Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer. J Clin Oncol 2015; 33: 141–8.
summary(ROSE_2A)
kmplot(ROSE_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.